Benoxinate Hydrochloride Suppliers & Bulk Manufacturers

Available Forms: Ophthalmic Solution

Available Strengths: 0.4% w/v

Reference Brands: Generic formulations marketed under different names

Category: Anaesthetics

Benoxinate Hydrochloride is available in Ophthalmic Solution and strengths such as 0.4% w/v. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Benoxinate Hydrochloride is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Benoxinate Hydrochloride can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Benoxinate Hydrochloride is a fast-acting topical local anesthetic primarily used in ophthalmology for temporary surface anesthesia of the eye. It works by blocking nerve impulse conduction at the corneal and conjunctival surface, providing rapid numbness within seconds of application. Due to its quick onset and short duration of action, it is especially suitable for diagnostic and minor therapeutic ophthalmic procedures where brief anesthesia is required.

This medication is commonly used prior to procedures such as tonometry, gonioscopy, removal of superficial foreign bodies, corneal scraping, and minor surgical or diagnostic interventions. Benoxinate Hydrochloride allows these procedures to be performed comfortably while minimizing patient discomfort and reflex blinking. It is typically administered as an ophthalmic solution and is intended strictly for professional clinical use.

Internationally, Benoxinate Hydrochloride is also known as oxybuprocaine hydrochloride and is widely recognized in European and UK markets under established ophthalmic anesthetic brands. Compared to some other topical ocular anesthetics, it is known for causing less stinging upon instillation, which improves patient tolerance. The drug is not intended for long-term or repeated use, as prolonged exposure may cause corneal irritation or damage. When used appropriately under medical supervision, Benoxinate Hydrochloride remains a reliable and essential agent in routine ophthalmic practice.